Drugs / DTPa-HBV-IPV/Hib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00325143 | Dec 2003 → Feb 2007 | diphtheria, haemophilus infectious disease, poliomyelitis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-HBV-IPV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00325143 ↗ |
| Modality | Vaccine | “Infanrix Hexa™ vaccine” NCT00325143 ↗ |
| Route | Intramuscular | “The Infanrix™-IPV/Hib and Infanrix Hexa™ vaccines were administered intramuscularly into the right antero-lateral thigh” NCT00325143 ↗ |